Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2007
06/07/2007US20070128252 Compositions and methods for treatment of body weight conditions
06/07/2007US20070128251 Process for manufacturing chewable dosage forms for drug delivery and products thereof
06/07/2007US20070128231 Phosphate-buffered solution with a pH of 5.9 to 6.8 containing tris(hydroxymethyl)aminomethane as a stabilizer; does not contain amino acids or human serum albumin; may also contain NaCl, ethylenediaminetetraacetic acid, and a nonionic detergent such as a polysorbate
06/07/2007US20070128202 inhibiting growth of cancerous cells using an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas
06/07/2007US20070128173 Use of polysulphated alginate in cellular matrices
06/07/2007US20070128167 Complexing agents for compositions containing inclusion complexes
06/07/2007US20070128156 Ophthalmic compositions containing a synergistic combination of two polymers
06/07/2007US20070128150 3-Maleimidyl-N-(2-{[3-maleimidyl-propionyl]-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-amino}-ethyl)-N-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-propionamide linked to 2 polyoxyethyelne glycol residue and two antibodies or fragments; conjugate; biodegradable
06/07/2007US20070128123 Stable aqueous solution for aerosol administering
06/07/2007US20070125418 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same
06/07/2007US20070125269 Highly Oil Absorbing Amorphous Silica Particles
06/07/2007CA2632181A1 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
06/07/2007CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof
06/07/2007CA2631784A1 Bifunctional metal chelating conjugates
06/07/2007CA2631335A1 Four branched dendrimer-peg for conjugation to proteins and peptides
06/07/2007CA2631123A1 Composition in the form of a spray containing a corticoid and an oil phase
06/07/2007CA2568825A1 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
06/06/2007EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof
06/06/2007EP1792927A1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
06/06/2007EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use
06/06/2007EP1792630A1 Conjugates of amino acids and vitamin B3 for percutaneous delivery of vitamin B3
06/06/2007EP1792628A1 Vaccines
06/06/2007EP1792626A1 Treatment of obesity by brain delivery of alpha-MSH and analogs thereof
06/06/2007EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
06/06/2007EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents
06/06/2007EP1792610A2 Sustained release bioadhesive therapeutic systems
06/06/2007EP1791959A2 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
06/06/2007EP1791873A1 New polymorphic form of inulin and uses thereof
06/06/2007EP1791571A2 Radiofluorinated peptides
06/06/2007EP1791565A2 Cysteine engineered antibodies and conjugates
06/06/2007EP1791564A2 Drying process for preserving an active agent as a highly viscous liquid
06/06/2007EP1791553A2 Compositions for delivering peptide yy and pyy agonists
06/06/2007EP1791547A1 Oral formulations of paricalcitol
06/06/2007EP1791529A2 P277 peptide formulations or variants thereof having optimised stability
06/06/2007EP1791524A2 Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose
06/06/2007EP1791519A2 Therapeutic foam
06/06/2007EP1542666B1 Modafinil pharmaceutical compositions
06/06/2007EP1392254B1 Micellar drug delivery systems for hydrophobic drugs
06/06/2007EP1363601B1 Amphoteric liposomes and the use thereof
06/06/2007EP1333865A4 Inorganic low density radionuclide coated particles
06/06/2007EP1333864A4 Low density radionuclide-containing particulate material
06/06/2007EP1289556B1 Isoflavones against radiation-induced mortality
06/06/2007EP1284146B1 Liposomes containing hydrophobic iodo compound
06/06/2007EP1283699B1 Injectable suspensions having improved injectability properties
06/06/2007EP1264181B1 Carriers coated with polysaccharides, their preparation and use
06/06/2007EP1158958B1 Improved powdery pharmaceutical compositions for inhalation
06/06/2007EP0839039B2 Paroxetine controlled release compositions
06/06/2007DE202007002287U1 Trägersubstanz insbesondere für Arzneimittel Vehicle especially for drugs
06/06/2007CN1977166A Detection of methamphetamine class of drugs
06/06/2007CN1976989A Gel-form water-absorbing material
06/06/2007CN1976948A 修饰的Exendins及其应用 Modified Exendins Its Applications
06/06/2007CN1976726A Compositions and methods for modulating bone mass
06/06/2007CN1976725A Dimensional analysis of saccharide conjugates with GPC & SEC-MALS
06/06/2007CN1976724A Meningococcal conjugate vaccination
06/06/2007CN1976716A Combined meningococcal conjugates with common carrier protein
06/06/2007CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes
06/06/2007CN1976688A Pegylated nanoparticles
06/06/2007CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component
06/06/2007CN1976679A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
06/06/2007CN1976581A Use of ether group-containing polymers as solubilizers
06/06/2007CN1973903A Oral vaccine of recombinant gene for preventing Helicobacter pylori infection and its prepn process
06/06/2007CN1973902A Anticancer medicine adriamycin composition with ginseng polyse as carrier and its prepn process
06/06/2007CN1973901A Composite microsphere prepn of lactic acid-hydroxyacetic acid copolymer and its prepn process
06/06/2007CN1973900A Matrix for Chinese medicine plaster and its prepn
06/06/2007CN1973876A Chinese medicine for treating kidney deficiency and its prpen
06/06/2007CN1973865A Medicine composition for treating apoplexy and its prepn
06/06/2007CN1973858A Large-fruit pungent litse fruit oil emulsion and its prepn process
06/06/2007CN1973849A Medicine composition for inducing diuresis to treat stranguria and its prepn process
06/06/2007CN1973847A Nasal liquid medicine for treating headache and its prepn process
06/06/2007CN1973843A Degradable polymer supported nanometer Daunorubicin microsphere and its prepn process
06/06/2007CN1973840A Long acting slow releasing drug addiction eliminating prepn and its prepn process and use
06/06/2007CN1973839A Nizatidine injection
06/06/2007CN1973838A Secnidazole tablet and its prepn process
06/06/2007CN1973837A Concentrated Tinidazole solution injection and its prepn process
06/06/2007CN1973836A Hydrophilic plaster for treating dysmenorrhea
06/06/2007CN1973834A Application of curcumin in preparing medicine for inventing drug resistance of malignant tumor
06/06/2007CN1973831A Magnetic slow releasing diclofenac sodium prepn in supermolecular intercalation structure and its prepn
06/06/2007CN1973830A Fast releasing solid omeprazole prepn and its prepn process
06/06/2007CN1973829A Process of preparing calcitonin microsphere
06/06/2007CN1973828A VEGF slowly releasing injection microsphere support and its prepn and use
06/06/2007CN1973827A Prepn process of superfine inhaled glucocorticoid medicine powder
06/06/2007CN1973824A Anticancer composition containing both platinum compound and Sirolimus
06/06/2007CN1973823A Anticancer composition containing Synergist
06/06/2007CN1973822A Anticancer composition containing Sirolimus
06/06/2007CN1973821A Medicine composition containing both anticancer medicine and its synergist
06/06/2007CN1973820A Anticancer composition containing Sirolimus and its application
06/06/2007CN1973819A Anticancer composition containing anticancer medicine and its synergist
06/06/2007CN1973818A Solid tumor treating medicine composition
06/06/2007CN1973817A Solid tumor treating slow releasing prepn containing chemotherapy synergist
06/06/2007CN1320112C Phytase formulation
06/06/2007CN1320036C Medical intelligent nano-gel material and its preparation method
06/06/2007CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors
06/06/2007CN1319598C A composition for external use
06/06/2007CN1319597C Polysaccharide-containing compositions and use thereof
06/06/2007CN1319592C Pharmaceutical formulations
06/06/2007CN1319537C Nano capsule containing glycyrrhizic acid medicine and its preparing method
06/06/2007CN1319535C Ribavirin syrup formulations
06/06/2007CN1319525C Taxinol-sodium alginate micro ball vascular embolism agent and its preparation
06/06/2007CN1319518C Oral pharmaceutical forms of liquid drugs having improved bioavailability
06/06/2007CN1319517C Low dose liquid entecavir formulations and use
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 1712